1 0

    FDA Review Documents for Cosentyx Approval in Hidradenitis Suppurativa (2023)

    FDA Review Documents for Cosentyx Approval in Hidradenitis Suppurativa (2023)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: We are requesting the FDA review documents for approving Cosentyx for the treatment of hidradenitis suppurativa in 2023. The FDA agent suggests that the documents were previously requested by other parties and are now available for distribution.
    Tags: Pharma, NDA, 2023

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details